| Product Code: ETC13162224 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Psoriasis Market was valued at USD 25 Billion in 2024 and is expected to reach USD 36 Billion by 2031, growing at a compound annual growth rate of 5.40% during the forecast period (2025-2031).
The global psoriasis market is experiencing steady growth, driven by increasing awareness, improved diagnosis rates, and advancements in treatment options. Biologic drugs have revolutionized the management of moderate to severe psoriasis, offering targeted therapy with fewer side effects compared to traditional systemic treatments. The market is also benefiting from ongoing research and development efforts to introduce novel therapies with better efficacy and safety profiles. Geographically, North America and Europe dominate the market due to high prevalence rates and greater healthcare expenditure. However, emerging markets in Asia-Pacific and Latin America are expected to witness significant growth due to improving healthcare infrastructure and rising patient awareness. Overall, the global psoriasis market is projected to continue expanding as healthcare providers and pharmaceutical companies focus on addressing the unmet needs of patients with psoriasis.
The Global Psoriasis Market is witnessing a growing demand for advanced biologic therapies and personalized treatment options for better management of the chronic skin condition. The market is expected to experience significant growth driven by increasing prevalence of psoriasis, rising awareness about the disease, and continuous research and development efforts by pharmaceutical companies. Moreover, the adoption of novel therapies such as IL-17 inhibitors and JAK inhibitors is expanding, offering new opportunities for market players to innovate and capture market share. With a focus on patient-centric care and the introduction of more targeted therapies, the Global Psoriasis Market presents promising prospects for market growth and improved patient outcomes in the coming years.
The Global Psoriasis Market faces several challenges, including limited treatment options for severe cases, high costs associated with biologic therapies, and varying efficacy rates among patients. Additionally, stigma and misconceptions surrounding the condition can lead to delays in diagnosis and treatment. Regulatory hurdles, such as lengthy approval processes for new treatments, also pose challenges for pharmaceutical companies. Furthermore, access to care and specialist providers may be limited in certain regions, leading to disparities in treatment outcomes. Overall, addressing these challenges requires a holistic approach that involves improving access to affordable treatments, increasing awareness and education, and fostering collaboration among healthcare stakeholders to enhance patient care and quality of life.
The global psoriasis market is primarily driven by factors such as the increasing prevalence of psoriasis worldwide, rising awareness about the condition among patients and healthcare professionals, advancements in treatment options including biologics and targeted therapies, and the growing demand for effective and long-term management of psoriasis symptoms. Additionally, the expanding research and development initiatives focused on developing innovative therapies for psoriasis, along with the rising healthcare expenditure and improving access to treatment options in emerging economies, are further driving the growth of the global psoriasis market. Moreover, the integration of technologies such as telemedicine and digital health solutions for remote monitoring and management of psoriasis patients is also contributing to the market expansion.
Government policies related to the Global Psoriasis Market primarily focus on ensuring access to effective treatments, promoting research and development for new therapies, and improving patient outcomes. This includes regulations for the approval and safety monitoring of psoriasis medications, funding for clinical trials and innovative treatments, and initiatives to raise awareness about the disease. Governments also aim to reduce healthcare costs associated with psoriasis by encouraging the use of generic drugs and biosimilars. Additionally, policies may address issues such as insurance coverage for psoriasis treatments, patient education programs, and support for healthcare providers in managing psoriasis cases. Overall, government policies in the Global Psoriasis Market aim to enhance the quality of care for patients, drive innovation in treatment options, and promote better overall health outcomes.
The Global Psoriasis Market is expected to witness steady growth in the coming years due to increasing awareness about the disease, advancements in treatment options, and a growing patient population. The market is driven by the introduction of innovative therapies such as biologics and targeted treatments, as well as the rising prevalence of psoriasis worldwide. Additionally, the growing emphasis on personalized medicine and the development of new pipeline drugs are anticipated to further propel market growth. However, challenges such as high treatment costs and regulatory hurdles may hinder market expansion to some extent. Overall, the Global Psoriasis Market is poised for sustained growth, driven by a combination of factors that cater to the evolving needs of patients and healthcare providers.
In the global psoriasis market, Asia is expected to witness significant growth due to the rising prevalence of psoriasis in countries like China and India. North America is a key market player, with a high prevalence of the disease and significant investments in research and development. Europe also holds a considerable market share, driven by the presence of well-established healthcare infrastructure and increasing awareness about psoriasis treatments. The Middle East and Africa region is experiencing growth due to improving healthcare facilities and rising awareness about psoriasis. Latin America is also emerging as a lucrative market, with increasing adoption of biologic therapies and expanding healthcare access. Overall, the global psoriasis market is expected to see continued growth across all regions due to factors such as increasing disease prevalence, advancements in treatment options, and rising healthcare expenditure.
Global Psoriasis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Psoriasis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Psoriasis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Psoriasis Market - Industry Life Cycle |
3.4 Global Psoriasis Market - Porter's Five Forces |
3.5 Global Psoriasis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Psoriasis Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Global Psoriasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Global Psoriasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 Global Psoriasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Psoriasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Psoriasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Psoriasis Market Trends |
6 Global Psoriasis Market, 2021 - 2031 |
6.1 Global Psoriasis Market, Revenues & Volume, By Types, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Psoriasis Market, Revenues & Volume, By Nail Psoriasis, 2021 - 2031 |
6.1.3 Global Psoriasis Market, Revenues & Volume, By Guttate Psoriasis, 2021 - 2031 |
6.1.4 Global Psoriasis Market, Revenues & Volume, By Psoriatic Arthritis, 2021 - 2031 |
6.2 Global Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Psoriasis Market, Revenues & Volume, By Tumour necrosis factor inhibitors, 2021 - 2031 |
6.2.3 Global Psoriasis Market, Revenues & Volume, By Vitamin D analogues, 2021 - 2031 |
6.2.4 Global Psoriasis Market, Revenues & Volume, By Interleukin-inhibitors, 2021 - 2031 |
6.3 Global Psoriasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Psoriasis Market, Revenues & Volume, By Physical Examination, 2021 - 2031 |
6.3.3 Global Psoriasis Market, Revenues & Volume, By Skin Biopsy, 2021 - 2031 |
6.4 Global Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Psoriasis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 Global Psoriasis Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.5 Global Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Psoriasis Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Psoriasis Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.5.4 Global Psoriasis Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Psoriasis Market, Overview & Analysis |
7.1 North America Psoriasis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Psoriasis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Psoriasis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Psoriasis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Psoriasis Market, Revenues & Volume, By Types, 2021 - 2031 |
7.4 North America Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.5 North America Psoriasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.6 North America Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Psoriasis Market, Overview & Analysis |
8.1 Latin America (LATAM) Psoriasis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Psoriasis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Psoriasis Market, Revenues & Volume, By Types, 2021 - 2031 |
8.4 Latin America (LATAM) Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.5 Latin America (LATAM) Psoriasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.6 Latin America (LATAM) Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Psoriasis Market, Overview & Analysis |
9.1 Asia Psoriasis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Psoriasis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Psoriasis Market, Revenues & Volume, By Types, 2021 - 2031 |
9.4 Asia Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.5 Asia Psoriasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.6 Asia Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Psoriasis Market, Overview & Analysis |
10.1 Africa Psoriasis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Psoriasis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Psoriasis Market, Revenues & Volume, By Types, 2021 - 2031 |
10.4 Africa Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.5 Africa Psoriasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.6 Africa Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Psoriasis Market, Overview & Analysis |
11.1 Europe Psoriasis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Psoriasis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Psoriasis Market, Revenues & Volume, By Types, 2021 - 2031 |
11.4 Europe Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.5 Europe Psoriasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.6 Europe Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Psoriasis Market, Overview & Analysis |
12.1 Middle East Psoriasis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Psoriasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Psoriasis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Psoriasis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Psoriasis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Psoriasis Market, Revenues & Volume, By Types, 2021 - 2031 |
12.4 Middle East Psoriasis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.5 Middle East Psoriasis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.6 Middle East Psoriasis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Psoriasis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Psoriasis Market Key Performance Indicators |
14 Global Psoriasis Market - Export/Import By Countries Assessment |
15 Global Psoriasis Market - Opportunity Assessment |
15.1 Global Psoriasis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Psoriasis Market Opportunity Assessment, By Types, 2021 & 2031F |
15.3 Global Psoriasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.4 Global Psoriasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.5 Global Psoriasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Psoriasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Psoriasis Market - Competitive Landscape |
16.1 Global Psoriasis Market Revenue Share, By Companies, 2024 |
16.2 Global Psoriasis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here